Shares of InMode Ltd INMD are trading lower Monday morning after the Israeli medical technology company said a special ...

根据新闻稿声明,该委员会成立的目的是评估潜在的收购提议,经判定收到的所有最终提议均不充分,也不符合公司及其股东的最佳利益。这家医疗技术提供商估值为9.64亿美元,市盈率为10.64,现已终止该流程。根据 InvestingPro 的分析,该股票相对于其公允价值似乎被低估,这表明委员会可能在等待更好的条件。

Following a careful review of the final proposals received in connection with the potential transaction, the Committee has ...

InMode halts control sale after rejecting final bids including Centroid Sale process shelved as InMode board rejects all final bids, including from Centroid ...

InMode表示,公司将继续审查其业务和增长战略,以及现金配置策略,重点是提升股东长期价值。该公司不打算就此事提供进一步更新,除非需要或必须进行额外披露。 Investing.com的 AI图表分析功能，能在一分钟内智能解读您的图表 并识别关键形态，同时精准筛选出当前最具参考价值的核心指标。 每次分析都提供 即时交易方案 ...

InMode remains a Hold as financial performance deteriorates, with flat 2026 revenue guidance and persistent margin compression. INMD's valuation is now almost entirely supported by its $500 ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...

YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

Investors in InMode Ltd. INMD need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 21, 2025 $10.00 Put had some of the highest implied ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...